Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MDxHealth | MDXH | Nov 15, 2024 | 1.64 | -6.29 |
Medalist Diversified REIT | MDRR | Nov 15, 2024 | 12.30 | +0.08 |
Medalist Diversified REIT A Pref | MDRRP | Nov 15, 2024 | 25.50 | +0.39 |
Medallion Bank F Pref | MBNKP | Nov 15, 2024 | 26.40 | -0.11 |
Medallion Financial | MFIN | Nov 15, 2024 | 9.53 | -1.75 |
MediaAlpha | MAX | Nov 15, 2024 | 11.74 | -5.09 |
Mediaco A | MDIA | Nov 15, 2024 | 1.08 | -6.09 |
Medical Properties Trust | MPW | Nov 15, 2024 | 4.31 | +0.70 |
MediciNova | MNOV | Nov 15, 2024 | 1.83 | +0.27 |
Medifast | MED | Nov 15, 2024 | 18.14 | -0.77 |
MEDIROM Healthcare Technologies ADR | MRM | Nov 15, 2024 | 2.64 | -2.15 |
MediWound | MDWD | Nov 15, 2024 | 16.00 | -2.26 |
Mednax | MD | Nov 15, 2024 | 14.15 | -4.13 |
Medpace | MEDP | Nov 15, 2024 | 310.63 | -7.23 |
Medtronic | MDT | Nov 15, 2024 | 87.53 | +1.78 |
Mega Matrix | MPU | Nov 15, 2024 | 1.62 | -4.71 |
Megacap 300 Growth Index ETF Vanguard | MGK | Nov 15, 2024 | 331.20 | -2.16 |
Megacap 300 Index ETF Vanguard | MGC | Nov 15, 2024 | 210.88 | -1.51 |
Megacap 300 Value Index ETF Vanguard | MGV | Nov 15, 2024 | 129.59 | -0.38 |
MEI Pharma | MEIP | Nov 15, 2024 | 2.92 | -2.99 |
Meihua International Medical Technologies | MHUA | Nov 15, 2024 | 0.47 | -5.39 |
MeiraGTx Holdings | MGTX | Nov 15, 2024 | 6.48 | -2.41 |
Meiwu Technology | WNW | Nov 15, 2024 | 0.85 | +6.38 |
Melar Acquisition I | MACIU | Nov 15, 2024 | 10.13 | 0.00 |
Melar Acquisition I | MACI | Nov 15, 2024 | 10.03 | -0.20 |
Melco Resorts & Entertainment ADR | MLCO | Nov 15, 2024 | 6.12 | -0.97 |
MercadoLibre | MELI | Nov 15, 2024 | 1 880.00 | +0.20 |
Mercantile Bank | MBWM | Nov 15, 2024 | 49.10 | -0.71 |
Mercer International | MERC | Nov 15, 2024 | 6.20 | -2.36 |
Merchants Bancorp | MBIN | Nov 15, 2024 | 40.19 | -0.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.